# Assessment of 18FLT PET-CT for Volume Definition of High-grade Gliomas (GLIO-TEP)

> **NCT00624728** · PHASE1,PHASE2 · COMPLETED · sponsor: **University Hospital, Bordeaux** · enrollment: 21 (actual)

## Conditions studied

- High-grade Glioma
- Astrocytoma
- Glioblastoma

## Interventions

- **RADIATION:** 18F Fluorothymidine PET CT

## Key facts

- **NCT ID:** NCT00624728
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2012-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00624728

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00624728, "Assessment of 18FLT PET-CT for Volume Definition of High-grade Gliomas (GLIO-TEP)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00624728. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*